drugset / Trial / NCT00669825
Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
Non-randomizedCrossoverSingle-blindBasic science
Summary
ALV003-0812 is a study of the safety and tolerability of a study drug (ALV003) in healthy adult volunteers and in patients with well-controlled celiac disease, following a meal that contains gluten.
Timeline
- Start
- 2008-03
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latiglutenase | Protein / enzyme biologic | 100 mg | Other |
| Comparator | Latiglutenase | Protein / enzyme biologic | 300 mg | Other |
| Comparator | Latiglutenase | Protein / enzyme biologic | 900 mg | Other |
| Comparator | Latiglutenase | Protein / enzyme biologic | 1800 mg | Other |